OBA Takaaki
Academic Assembly School of Medicine and Health Sciences Institute of Medicine
Shinshu University Hospital Clinical Division of Breast and Endocrine Surgery
Senior Assistant Professor
Researcher Information
Research activity information
Paper
- Fluctuations in Gut MicrobiomeComposition During Immune Checkpoint Inhibitor Therapy.
Sarkar J, Cortes Gomez E, Oba T, Chen H, Dy GK, Segal BH, Ernstoff MS, Ito F.
World J Oncol., 2023 - Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell LungCancer Patients Treated with Chemo-Immunotherapy.
Abdelfatah E, Long MD, Kajihara R, Oba T, Yamauchi T, Chen H, Sarkar J, Attwood K, Matsuzaki J, Segal B, DyGK, Ito F.
Cancer Res Commun, 2023 - Changes in thepathophysiology of primary hyperparathyroidism and analysis of postoperative recurrence cases at a regional corehospital in Japan: experience of 35 years in Shinshu University Hospital.
Kanai T, Oba T, Morikawa H, Amitani M, Chino T, Shimizu T, Ono MT, Maeno K, Ito KI, Ito T.
Ann Palliat Med., 2023 - The Advantage of Using an Optical See-Through Head-Mounted Displayin Ultrasonography-Guided Needle Biopsy Procedures: A Prospective Randomized Study.
Shimizu T, Oba T (co-first author), Ito KI.
J Clin Med, 2023 - Neutrophil-to-lymphocyte ratio is associated with the proportion of poorly differentiated components in papillarythyroid carcinoma.
Oba T, Kazuma M, Kiyosawa N, Morikawa H, Amitani M, Chino T Shimizu T, Ono M, Ito T, Kanai T, Ito KI.
J Surg Res, 2023 - A Case of a Cystic Parathyroid Adenoma with Marked Hyperparathyroidism but Difficult Preoperative Diagnostic Imaging
KUBOTA Satoshi, SHIMADA Yasuho, TAKAYAMA Shohei, OBA Takaaki, ITO Ken-ichi, KOMATSU Mitsuhisa
The Shinshu Medical Journal, 70(3), 189-194, Jun. 2022
- CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1(+) CD8(+) T cells
Yamauchi, Takayoshi; Hoki, Toshifumi; Oba, Takaaki; Kajihara, Ryutaro; Attwood, Kristopher; Cao, Xuefang; Ito, Fumito;
CANCER IMMUNOLOGY IMMUNOTHERAPY, 71(1), 137-151, Jan. 2022
- The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time
Ono, Mayu; Oba, Takaaki; Shibata, Tomohiro; Ito, Ken-Ichi;
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147(11), 3211-3224, Nov. 2021 - In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models
Oba, Takaaki; Makino, Kenichi; Kajihara, Ryutaro; Yokoi, Toshihiro; Araki, Ryoko; Abe, Masumi; Minderman, Hans; Chang, Alfred E.; Odunsi, Kunle; Ito, Fumito;
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9(5), e002432, May 2021 - HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells
Oba T, Ono M, Matoba H, Uehara T, Hasegawa Y, Ito KI.
Breast Cancer Res Treat., 186(1), 37-51, Feb. 2021 - Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin
Oba, Takaaki; Maeno, Kazuma; Ono, Mayu; Ito, Tokiko; Kanai, Toshiharu; Ito, Ken-ichi;
Anticancer Research, 41(1), 445-452, Jan. 2021 - Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
9. Watanabe T, Oba T, Tanimoto K, Shibata T, Kamijo S, Ito KI.
PLOS ONE, 2021 - Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature.
11. Shimizu T, Oba T, Chino T, Soma A, Ono M, Ito T, Kanai T, Maeno K, Sato Y, Uehara T, Ito KI.
Thyroid Res, 2021 - Fibroadenoma in a young male breast: A case report and review of the literature.
13. Morikawa H, Nobuoka M, Amitani M, Shimizu T, Ohno K, Ono M, Oba T, Ito T, Kanai T, Maeno K, Uehara T, Ito KI.
Clin Case Rep., 2021 - Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors
Oba, Takaaki; Kajihara, Ryutaro; Yokoi, Toshihiro; Repasky, Elizabeth A.; Ito, Fumito;
CANCER RESEARCH, 81(24), 6183-6195, 2021 - Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression
Patel, Ankit; Oba, Takaaki; Kajihara, Ryutaro; Yokoi, Toshihiro; Abrams, Scott I.; Ito, Fumito;
JOURNAL OF IMMUNOLOGY, 207(5), 1298-1309, 2021 - Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer
Yokoi, Toshihiro; Oba, Takaaki; Kajihara, Ryutaro; Abrams, Scott, I; Ito, Fumito;
SCIENTIFIC REPORTS, 11(1), 21992, 2021 - T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors
Yamauchi, Takayoshi; Hoki, Toshifumi; Oba, Takaaki; Jain, Vaibhav; Chen, Hongbin; Attwood, Kristopher; Battaglia, Sebastiano; George, Saby; Chatta, Gurkamal; Puzanov, Igor; Morrison, Carl; Odunsi, Kunle; Segal, Brahm H.; Dy, Grace K.; Ernstoff, Marc S.; Ito, Fumito;
NATURE COMMUNICATIONS, 12(1), 1402, 2021 - Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer
Oba, Takaaki; Maeno, Kazuma; Amitani, Masatsugu; Shimizu, Tadafumi; Ohno, Koichi; Ono, Mayu; Ito, Tokiko; Kanai, Toshiharu; Uehara, Takeshi; Ito, Ken-Ichi;
Endocrine journal, 68(11), 1329-1336, 2021 - Multicenter retrospective study on the use of Curebest (TM) 95GC Breast for estrogen receptor-positive and node-negative early breast cancer
Tsukamoto, Fumine; Arihiro, Koji; Takahashi, Mina; Ito, Ken-ichi; Ohsumi, Shozo; Takashima, Seiki; Oba, Takaaki; Yoshida, Masayuki; Kishi, Kazuki; Yamagishi, Keisuke; Kinoshita, Takayuki;
BMC CANCER, 21(1), 1077, 2021
